MLTX Insider Trading

Insider Ownership Percentage: 12.02%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $9,186,120.00

MoonLake Immunotherapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at MoonLake Immunotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$60M-$40M-$20M$0$20M$40M$60MTotal Insider BuyingTotal Insider Selling

MoonLake Immunotherapeutics Share Price & Price History

Current Price: $38.05
Price Change: Price Increase of +1.7 (4.68%)
As of 04/2/2025 05:00 PM ET

This chart shows the closing price history over time for MLTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$36.35Closing price on 04/01/25:

SEC Filings (Institutional Ownership Changes) for MoonLake Immunotherapeutics (NASDAQ:MLTX)

93.85% of MoonLake Immunotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MLTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$156Mbought$118MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100M$0$100MTotal InflowsTotal Outflows
MoonLake Immunotherapeutics logo
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.
Read More on MoonLake Immunotherapeutics

Today's Range

Now: $38.05
Low: $35.39
High: $38.63

50 Day Range

MA: $41.89
Low: $36.35
High: $47.12

52 Week Range

Now: $38.05
Low: $35.85
High: $58.26

Volume

680,471 shs

Average Volume

342,392 shs

Market Capitalization

$2.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

Who are the company insiders with the largest holdings of MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics' top insider shareholders include:
  1. Bihua Chen (Major Shareholder)
  2. Da Silva Jorge Santos (CEO)
  3. Matthias Bodenstedt (CFO)
  4. Simon Sturge (Director)
  5. Kristian Reich (Insider)
Learn More about top insider investors at MoonLake Immunotherapeutics.